AKRO - Akero Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AKRO (1744659)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
90 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-11-15
AKROYale CatrionaChief Development OfficerS - Sale+OE$27.73-9,06174,158-11%-$251,274
D
2024-11-06
AKROYale CatrionaChief Development OfficerS - Sale+OE$35.19-10,00074,158-12%-$351,890
D
2024-11-01
AKROYoung JonathanCOOS - Sale+OE$31.57-50,716276,286-16%-$1,601,252
D
2024-11-01
AKROCheng AndrewPres, CEOS - Sale+OE$31.73-108,366605,417-15%-$3,438,312
DM
2024-10-30
AKROYale CatrionaChief Development OfficerS - Sale+OE$32.60-20,00074,158-21%-$651,960
DM
2024-10-16
AKROCheng AndrewPres, CEOS - Sale+OE$31.41-91,634605,417-13%-$2,878,038
D
2024-10-14
AKROYoung JonathanCOOS - Sale+OE$30.15-40,000286,286-12%-$1,206,080
DM
2024-10-15
AKROYale CatrionaChief Development OfficerS - Sale+OE$30.37-20,96174,158-22%-$636,490
2024-10-01
AKROYoung JonathanCOOS - Sale$28.18-10,000286,286-3%-$281,770
D
2024-09-20
AKROYale CatrionaChief Development OfficerS - Sale+OE$27.65-5,50075,294-7%-$152,086
DM
2024-09-16
AKROYale CatrionaChief Development OfficerS - Sale+OE$27.54-8,39375,294-10%-$231,175
2024-09-10
AKROYoung JonathanCOOS - Sale$26.18-568296,2860%-$14,870
2024-09-10
AKROYale CatrionaChief Development OfficerS - Sale$26.18-63775,294-1%-$16,677
2024-09-10
AKROWhite William RichardCFOS - Sale$26.18-63941,152-2%-$16,729
2024-09-10
AKRORolph TimothyChief Scientific OfficerS - Sale$26.18-537180,7050%-$14,059
2024-09-10
AKROCheng AndrewPres, CEOS - Sale$26.18-1,738605,4170%-$45,501
2024-09-03
AKROYoung JonathanCOOS - Sale$26.72-5,000296,854-2%-$133,588
D
2024-09-03
AKROYale CatrionaChief Development OfficerS - Sale+OE$27.61-94975,931-1%-$26,206
DM
2024-08-26
AKROWhite William RichardCFOS - Sale+OE$27.02-98,33441,791-70%-$2,657,250
DM
2024-08-23
AKROYale CatrionaChief Development OfficerS - Sale+OE$27.52-14,05175,931-16%-$386,714
2024-08-01
AKROYoung JonathanCOOS - Sale$26.75-5,000301,854-2%-$133,756
DM
2024-07-23
AKROWhite William RichardCFOS - Sale+OE$27.07-161,85541,791-79%-$4,381,867
D
2024-07-16
AKROWhite William RichardCFOS - Sale+OE$28.05-34,81141,791-45%-$976,274
2024-07-01
AKROYoung JonathanCOOS - Sale$23.40-5,000306,854-2%-$117,020
2024-06-11
AKROYoung JonathanCOOS - Sale$22.64-2,516310,790-1%-$56,965
2024-06-11
AKROYale CatrionaChief Development OfficerS - Sale$22.64-2,82574,867-4%-$63,961
2024-06-11
AKROWhite William RichardCFOS - Sale$22.64-2,83146,799-6%-$64,094
2024-06-11
AKRORolph TimothyChief Scientific OfficerS - Sale$22.64-2,380180,178-1%-$53,886
2024-06-11
AKROLamy PatrickSVP, Commercial StrategyS - Sale$22.64-56918,562-3%-$12,883
2024-06-11
AKROCheng AndrewPres, CEOS - Sale$22.64-7,894581,553-1%-$178,728
2024-06-03
AKROYoung JonathanCOOS - Sale$19.29-5,000313,306-2%-$96,440
2024-05-01
AKROYoung JonathanCOOS - Sale$20.15-5,000318,306-2%-$100,750
2024-04-01
AKROYoung JonathanCOOS - Sale$24.38-5,000587,012-1%-$121,913
2024-03-13
AKROYale CatrionaChief Development OfficerS - Sale$28.33-72377,692-1%-$20,483
2024-03-13
AKROWhite William RichardCFOS - Sale$28.33-72449,630-1%-$20,511
2024-03-13
AKROCheng AndrewPres, CEOS - Sale$28.33-1,969589,4470%-$55,782
2024-03-13
AKROYoung JonathanCOOS - Sale$28.33-651328,3060%-$18,443
2024-03-13
AKRORolph TimothyChief Scientific OfficerS - Sale$28.33-619182,5580%-$17,536
D
2024-03-04
AKROCheng AndrewPres, CEOS - Sale+OE$32.87-75,000591,416-11%-$2,465,063
D
2024-03-04
AKROYale CatrionaChief Development OfficerS - Sale+OE$35.49-20,64678,415-21%-$732,727
D
2023-12-27
AKROYoung JonathanCOOS - Sale+OE$24.00-5,414245,131-2%-$129,936
2023-12-14
AKROYale CatrionaChief Development OfficerS - Sale$20.76-59777,910-1%-$12,394
2023-12-14
AKROWhite William RichardCFOS - Sale$20.76-61150,354-1%-$12,684
2023-12-14
AKROYoung JonathanCOOS - Sale$20.76-543245,1310%-$11,273
2023-12-14
AKROCheng AndrewPres, CEOS - Sale$20.76-1,628550,9110%-$33,797
2023-12-14
AKRORolph TimothyChief Scientific OfficerS - Sale$20.76-514182,6720%-$10,671
2023-12-08
AKROGraham G. WalmsleyDirP - Purchase$19.83+100,000802,168+14%+$1,982,940
DM
2023-12-07
AKROCheng AndrewPres, CEOS - Sale+OE$20.02-26,978552,539-5%-$539,969
M
2023-11-30
AKROGraham G. WalmsleyDirP - Purchase$16.95+100,000702,168+17%+$1,694,565
2023-11-17
AKROYoung JonathanCOOS - Sale$14.68-30,000213,177-12%-$440,259
D
2023-10-02
AKROCheng AndrewPres, CEOS - Sale+OE$47.91-25,000460,998-5%-$1,197,827
D
2023-10-02
AKROYoung JonathanCOOS - Sale+OE$51.10-490243,1770%-$25,039
2023-09-13
AKROCheng AndrewPres, CEOS - Sale$50.34-1,682460,9980%-$84,672
2023-09-13
AKROWhite William RichardCFOS - Sale$50.34-63218,468-3%-$31,815
DM
2023-09-13
AKROYale CatrionaChief Development OfficerS - Sale+OE$48.32-5,61746,010-11%-$271,416
2023-09-13
AKRORolph TimothyChief Scientific OfficerS - Sale$50.34-531150,6890%-$26,731
2023-09-13
AKROYoung JonathanCOOS - Sale$50.34-562243,1770%-$28,291
D
2023-09-01
AKROCheng AndrewPres, CEOS - Sale+OE$49.77-25,000462,680-5%-$1,244,248
D
2023-08-28
AKROYale CatrionaChief Development OfficerS - Sale+OE$49.99-5,74546,627-11%-$287,191
2023-08-08
AKROGraham G. WalmsleyDirP - Purchase$42.06+25,000602,168+4%+$1,051,475
D
2023-08-01
AKROCheng AndrewPres, CEOS - Sale+OE$43.15-25,000447,680-5%-$1,078,867
M
2023-07-28
AKROGraham G. WalmsleyDirP - Purchase$42.95+55,000577,168+11%+$2,362,234
D
2023-07-03
AKROCheng AndrewPres, CEOS - Sale+OE$44.88-25,000447,680-5%-$1,122,041
M
2023-06-21
AKROYale CatrionaChief Development OfficerS - Sale$51.74-33,34946,627-42%-$1,725,390
D
2023-06-20
AKROWhite William RichardCFOS - Sale+OE$55.00-20,77719,100-52%-$1,142,735
D
2023-06-16
AKROHeyman Tomas J.DirS - Sale+OE$54.67-26,0000-100%-$1,421,529
D
2023-06-16
AKROHenderson JaneDirS - Sale+OE$54.17-40,0000-100%-$2,166,685
D
2023-06-16
AKRORolph TimothyChief Scientific OfficerS - Sale+OE$54.78-78,200151,220-34%-$4,284,066
2023-06-13
AKROWhite William RichardCFOS - Sale$55.16-60622,377-3%-$33,427
2023-06-13
AKROCheng AndrewPres, CEOS - Sale$55.16-1,613407,6800%-$88,973
2023-06-13
AKRORolph TimothyChief Scientific OfficerS - Sale$55.16-509189,4200%-$28,076
2023-06-13
AKROYoung JonathanCOOS - Sale$55.16-538243,7390%-$29,676
2023-06-13
AKROYale CatrionaChief Development OfficerS - Sale$55.16-59179,976-1%-$32,600
AM
2022-09-19
AKROGraham G. WalmsleyDirP - Purchase$29.69+520,000522,168>999%+$15,440,000
D
2023-06-01
AKROCheng AndrewPres, CEOS - Sale+OE$45.10-25,000409,293-6%-$1,127,430
M
2023-09-19
AKROGraham G. WalmsleyDirP - Purchase$29.69+520,000522,168>999%+$15,440,000
D
2023-05-01
AKROCheng AndrewPres, CEOS - Sale+OE$45.07-25,000409,293-6%-$1,126,860
D
2023-04-03
AKROCheng AndrewPres, CEOS - Sale+OE$37.94-25,000369,293-6%-$948,576
D
2023-03-01
AKROCheng AndrewPres, CEOS - Sale+OE$46.65-25,000370,999-6%-$1,166,338
D
2023-02-01
AKROCheng AndrewPres, CEOS - Sale+OE$49.06-25,000370,999-6%-$1,226,395
2023-01-13
AKROYale CatrionaChief Development OfficerS - Sale$50.53-5,00081,268-6%-$252,651
D
2023-01-03
AKROCheng AndrewPres, CEOS - Sale+OE$51.27-25,000370,999-6%-$1,281,751
D
2023-01-03
AKROYoung JonathanCOOS - Sale+OE$54.64-8,777244,911-3%-$479,560
DM
2022-12-28
AKRORolph TimothyChief Scientific OfficerS - Sale+OE$50.97-22,016190,532-10%-$1,122,125
DM
2022-12-27
AKROWhite William RichardCFOS - Sale+OE$49.77-20,00023,624-46%-$995,323
D
2022-12-27
AKROYoung JonathanCOOS - Sale+OE$49.57-12,500242,449-5%-$619,609
D
2022-12-12
AKROYale CatrionaChief Development OfficerS - Sale+OE$43.23-5,00086,268-5%-$216,137
2022-12-01
AKROSkorpios TrustFormer 10% ownerS - Sale$43.50-1,636,0003,271,829-33%-$71,166,000
D
2022-12-01
AKROCheng AndrewPres, CEOS - Sale+OE$46.07-10,000310,148-3%-$460,700
2022-11-30
AKROHarrison Seth LoringDirS - Sale$46.94-23,131284,364-8%-$1,085,739

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top